Protocol for faecal microbiota transplantation in irritable bowel syndrome: the MISCEAT study – a randomised, double-blind cross-over study using mixed microbiota from healthy donors

INTRODUCTION: Several studies have demonstrated dysbiosis in irritable bowel syndrome (IBS). Therefore, faecal microbiota transplantation, whose effect and safety have been proven in Clostridioides difficile infections, may hold promise in other conditions, including IBS. Our study will examine the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hurych, Jakub, Vejmelka, Jiri, Hlinakova, Lucie, Kramna, Lenka, Larionov, Vladyslav, Kulich, Michal, Cinek, Ondrej, Kohout, Pavel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Gastroenterology and Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237876/
https://www.ncbi.nlm.nih.gov/pubmed/35760542
http://dx.doi.org/10.1136/bmjopen-2021-056594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237876/
https://www.ncbi.nlm.nih.gov/pubmed/35760542
http://dx.doi.org/10.1136/bmjopen-2021-056594

Ejemplares similares